Medications

Article

AAEP 2003: Compounding

February 03, 2004

Charlotte A. Lacroix, DVM, Esq. (attorney) of New Jersey, presented a session on compounding at the convention. Lacroix cautioned her veterinary audience that illegal compounding is a potential tidal wave in liability.

The FDA says a dru... Read More

Article

AAEP 2003: Medications and Drug Testing

February 03, 2004

A packed room during the AAEP’s Racing Forum held sometimes heated discussions about the facts and nuances of the on-going Racing Medication and Testing Consortium’s (RMTC) attempt to create a uniform medication policy for racing in the United... Read More

Article

Alleviating Acute and Chronic Hind Limb Pain

January 31, 2004

Musculoskeletal pain associated with acute and chronic hind limb injuries is common in equine practice. Unabated pain can result in complications such as gastrointestinal disorders and supporting limb laminitis. Pain management is critical to decreas... Read More

Article

New EPM Treatment Approved

January 01, 2004

On Nov. 19 the U.S. Food and Drug Administration (FDA) approved Navigator for treating equine protozoal myeloencephalitis (EPM). This drug has been under development for more than six years.

IDEXX Laboratories of Westbrook, Maine, received... Read More

Article

Graded Stakes Drug Testing Plan to Begin in July

December 30, 2003

The American Graded Stakes Committee has set July 2004 as the target date for implementation of a more stringent drug testing policy for all graded stakes that will require tests for more than 140 parent drugs and their metabolites.

The... Read More

Article

Good and Bad Drugs

December 03, 2003

So what do veterinarians talk about when they get together? Pretty much what other horse people talk about--successes, problems, the high cost of doing business, and the latest “hot” topics of the industry. At the 2003 gathering of the American... Read More

Article

More on the New EPM Treatment

December 03, 2003

(Revised 12/5/03) Horse owners have a new option for treating equine protozoal myeloencephalitis (EPM) following the Nov. 19 U.S. Food and Drug Administration's (FDA) approval of nitazoxanide. This medication has been under development... Read More

Article

Ivermectin/Praziquantel Safe For Pregnant Mares And Foals

December 01, 2003

A recent study completed by French and Brazilian veterinarians showed that administration of ivermectin/praziquantel paste, a common equine dewormer combination, is safe for pregnant mares and their foals. Dewormers of this type have not yet bee... Read More

Article

West Nile Virus Treatment: Plasma Product Licensed

November 05, 2003

Since December 2001, the donors have been vaccinated multiple times with the West Nile Virus vaccine. The company had to prove purity, safety, and reasonable expectation of efficacy to have the plasma conditionally licensed for treating WNV.... Read More

Article

Folic Acid Supplementation

November 01, 2003

Sulphadiazine and pyrimethamine are used in combination to treat equine protozoal myeloencephalitis (EPM). These drugs interfere with folic acid (folate) metabolism, a vitamin essential for survival of the causative protozoon Sarcocystis... Read More

Article

Compounding Roundtable

November 01, 2003

The Animal Medicinal Drug Use Clarification Act of 1994 states that it is illegal to produce a compounded drug designed to treat a disease or condition when an FDA-approved drug for the disease or condition is available. As an exception to this... Read More

Article

Kentucky Drug Council Partners with UK to Study Inolin, Dizocilpine

October 28, 2003

The Kentucky Equine Drug Research Council is moving forward on research to develop tests for presence of the drugs inolin, a bronchodilator which could also enhance performance, and dizocilpine, a potential stimulant. The council is also working... Read More

Article

Compounding Roundtable Transcript

October 22, 2003

Following is the transcript of the Roundtable Discussion on Compounding for the Equine Veterinary Profession sponsored by Luitpold Animal Health and held in New York on Aug. 30. In attendance were Gary White, DVM (Luitpold Pharmaceuticals, who... Read More

Article

Steroid Effects on the Knees

October 01, 2003

During intensive training, young racehorses experience a thickening in the layers of bone under the cartilage of joints. These layers, called subchondral (located nearer the surface) and cancellous, become harder and better able to handle the... Read More

Article

WNV Treatment Licensed

October 01, 2003

Novartis Animal Vaccines announced Aug. 19 the conditional licensing and availability of the only antibody product approved by the USDA to help control disease caused by West Nile virus (WNV) in equids. This product helps an exposed animal by... Read More

Article

More on the Licensed WNV Treatment

September 10, 2003

Novartis Animal Vaccines announced Aug. 19 the conditional licensing and availability of the only antibody product approved by the USDA to help control disease caused by West Nile virus (WNV) in equids. This product helps an exposed animal by... Read More

Article

Hyperimmune Plasma for WNV Horses

September 10, 2003

Veterinarians have been using an antibody product to treat West Nile virus (WNV) clinical signs, but its use for this purpose is currently off-label (not approved by the USDA). Currently, the hyperimmune plasma product HiGamm-Equi, by Lake... Read More

Article

West Nile Virus Treatment Licensed

September 05, 2003

Novartis Animal Vaccines announced Aug. 19 the conditional licensing and availability of the only antibody product approved by the USDA to help control disease caused by West Nile virus (WNV) in equids. This product helps an exposed animal by... Read More

Article

Veterinarians Discuss Compounding's Impact

September 03, 2003

On Aug. 30, Luitpold Pharmaceuticals hosted a soon-to-be published roundtable discussion on the illegal compounding of equine veterinary drugs.

"We have seen an alarming increase in the amount of compounded medications sold to equine... Read More

Article

Dealing With EPM Today

September 01, 2003

While West Nile virus continues to dominate headlines when it comes to equine health, researchers are working to unlock the mysteries of that other, not-quite-so-new disease--equine protozoal myeloencephalitis (EPM). High on the list is... Read More

Article

Remaining Saddlebred Recovering Well

August 12, 2003

Cats Don't Dance, the remaining injured Saddlebred under veterinary treatment at Hagyard-Davidson-McGee (HDM) Associates in Lexington, Ky., is recovering well and might be returning home sometime next week, according to his treating... Read More

Article

Hospitalized Saddlebred Continues to Heal

July 30, 2003

The one sabotaged Saddlebred still under treatment is recovering well, according to two veterinarians who have been treating the horse at Hagyard-Davidson-McGee (HDM) Associates in Lexington, Ky. However, they cannot say the gelding is... Read More

Article

Update on Two Surviving Saddlebreds

July 22, 2003

Cats Don't Dance, one of the two surviving American Saddlebreds injected with a caustic substance several weeks ago, was recovering yesterday (June 21) at Hagyard-Davidson-McGee Associates (HDM) in Lexington, Ky. Nathan Slovis, DVM, Dipl. ACVIM... Read More

Article

Saddlebred Attack Turns Deadly

July 17, 2003

Two of the American Saddlebreds attacked and injected with a caustic substance in their left front pasterns were euthanized early today (July 17) in Versailles, Ky., due to complications from their injuries.... Read More

Article

Injured Saddlebreds Continue Treatment: One Still in Critical Condition

July 16, 2003

Five American Saddlebreds injected with an unknown caustic substance several weeks ago continue to recover from their injuries under the care of several practitioners. Hyperbaric oxygen chamber therapy continues for the animals, and a medication... Read More